• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Plasma Apolipoprotein Mutants and their Implication on Lipoprotein Metabolism

Research Project

Project/Area Number 02671116
Research Category

Grant-in-Aid for General Scientific Research (C)

Allocation TypeSingle-year Grants
Research Field 内分泌・代謝学
Research InstitutionNational Cardiovascular Center Research Institute

Principal Investigator

YAMAMURA Taku  National Cardiovascular Center Research Institute, Department of Etiology and Pahtophysiology, Head of Laboratory, 病因部, 室長 (20132938)

Co-Investigator(Kenkyū-buntansha) IKEDA Yasuyuki  National Cardiovascular Center Research Institute, Department of Etiology and Pa, 病因部, 室長 (90176107)
MIYAKE Yasuo  National Cardiovascular Center Research Institute, Department of Etiology and Pa, 病因部, 室長 (00132936)
Project Period (FY) 1990 – 1991
Project Status Completed (Fiscal Year 1991)
Budget Amount *help
¥2,300,000 (Direct Cost: ¥2,300,000)
Fiscal Year 1991: ¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 1990: ¥1,400,000 (Direct Cost: ¥1,400,000)
KeywordsApolipoprotein E / Atherosclerosis / Lipoprotein / LDL receptor / Mutant
Research Abstract

Serum lipoproteins and apo E were analyzed from 199 patients in CCU, having angina pectoris or myocardial infarction, and from 211 healthy subjects. The frequency of apo E4 was higher and that of E2 was lower in the CCU group than in the control group. Apo E mutants, E7 and E5, were also frequent in the CCU group. When we examined serum lipoproteins by the apo E phenotypes, the subjects with an E3/2 phenotype had reduced LDL and increased very low density lipoprotein (VLDL) concentrations, and those with an E4/3 phenotype had increased LDL levels in serum. The results suggested that the E4 and E2 isoproteins were positive and negative risk factors for atherosclerosis, respectively. One of the mechanisms of atherosclerosis is associated with the action of apo E isoproteins on serum LDL levels.
We have previously demonstrated unique isoproteins of apo E (apo E5 and E7) associated with liyperlipidemia and atlierosclerosis. Gene analysis of E5 showed that a G to A substitution had resulted … More in a Glu to Lys substitution at the third position of the mature protein. F, 7 had two G to A substitutions, resulting in -Glu-Glu- to -Lys-Lys- substitution at positions 244 and 245. We characterized the activity of apo E5 and apo E7 binding to LDL receptors on human fibroblasts. The affinity of apo E5 was twice that of wild form of apo E3. Apo E7, however, had a lower receptor affinity than apo E3. The high affinity, of apo E5 may result in a high uptake of apo E5-containing lipoproteins by the liver and lead to a down-regulation of LDL receptors in the liver. We can postulate that the subjects with apo E5 are susceptible to hypercholesterolemia and in consequence to atherosclerosis.
We developed a rapid, accurate, and sensitive method for determining apo E molecular species, and to utilize this method we investigated the relationship between apo E isoproteins and serum lipoprotein metabolism in children. Apo E phenotypes and serum lipoprotein levels were determined in 767 school children aged 7, 10 and 13 years old. Apo E phenotyping was performed by immunoblotting of an isoelectric focusing gel. Serum samples were treated with neuraminidase before delipidation. Serum cholesterol and LDL-cholesterol concentrations increase'd in the order of E3/2 -> 1/2 E3/3 -> E4/3 in each agegroup. The effect of the apo E polymorphism in serum apo B was the same tendency as cholesterol levels, but the opposite effect on serum apo E concentrations was observed. It was noteworthy that the effect of apo E isoforms on serum lipoproteins had been revealed even in childhood. We suggest the possibility that hyperlipoproteinemia and atherosclerosis miglit be prevent by dietary control based on apo E phenotypes early in life. Less

Report

(3 results)
  • 1991 Annual Research Report   Final Research Report Summary
  • 1990 Annual Research Report
  • Research Products

    (31 results)

All Other

All Publications (31 results)

  • [Publications] Taku Yamamura: "Hyperlipoproteinemia as a risk factor for ischemic heart disease" Jpn.Circ.J.54. 448-456 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "アポEイン蛋白のLDLーレセプタ-への結合能について" 動脈硬化. 18. 263-268 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "動脈硬化症におけるアポリポ蛋白異常" 動脈硬化研究の進歩. 11. 25-33 (1990)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "アポE isoform" 現代医療. 23. 171-174 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "アポEの異常と動脈硬化" 医学のあゆみ. 157. 832-836 (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Li-Ming Dong: "Site-directed mutagenesis of an apoE mutant,apoE5(Glu_3→Lys):the binding activity of the expressed apoE5 to LDL receptor" Biochem.Biophys.Res.Commun.(1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "最新内科学大系36「動脈硬化と脈管疾患」「高脂血症」" 中山書店, 394(108-115) (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] 山村 卓: "高脂血症「アポ蛋白とその役割り」" 南江堂, 264(170-176) (1991)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Dong, L. -M., Yamamura, T., Yamamoto, A.: "Enhanced binding activity of an apolipoprotein E mutant, apo E5, to LDL receptors on human fibroblasts. Biochem. Biophys." Res. Commun.168. 409-414 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamamura, T., Tajima, S., Miyake, Y., Nomura, S., Yamamoto, A., Haze, K. and Hiramori, K.: "Hyperlipoproteinemia as a risk factor for ischemic heart disease." Jpn. Circ. J.54. 448-456 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamamura, T.: "Cardiovascular disease, hyperlipidemia and coagulation : editorial comment." Current Opinion in Lipidology. 1. 175-178 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamamoto, A., Yamamura, T., Tajima, S.: "Risk factors for atherosclerotic vascular diseases with special reference to the relationship between apolipoprotein E mutations and hyperlipidemia." Ann. N. Y. Acad. Sci.598. 58-95 (1990)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Yamamoto, A., Yamamura, T., Kawaguchi, A., Kameda, K. and Matsuzawa, Y.: "Triglyceride and glucose intolerance as a risk factor for coronary heart disease." Cardiology. 78. 185-193 (1991)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Mezdour, H., Nomura, S., Yamamura, T. and Yamamoto, A.: "Concentration and distribution of apolipoprotein AI and E in normolipidemic, WHHL, and diet-induced hyperlipidemic rabbit sera." Biochim. Biophys. Acta.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Miyake, Y., Tajima, S., Funahashi, T., Yamamura, T. and Yamaoto, A.: "A point mutation of low density lipoprotein receptor causing rapid degradation of the receptor." J. Clin. Invest.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Nomura. S., Yamamura, T., Yamamoto, A., Haze, Hiramori, K., Hara, H., Yamaguchi, T., and Pokrovsky, S. N.: "The association between lipoprotein(a) and severity of coronary and cerebral atherosclerosis, especially in normocholesterolemic subjects." Atherosclerosis.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Dong, L. -M., Yamamura, T., Tajima, S. and Yamamoto, A.: "Site-directed mutagenesis of an apo E mutant, apo E5(Glu_3->Lys) : the binding activity of the expressed apo E5 to LDL receptors. Biochem." Biophys. Res. Commun.

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1991 Final Research Report Summary
  • [Publications] Taku Yamamura: "Hyperlipoproteinemid as a risk factor for ischemic heart disease" Tpn.Circ.J.54. 448-456 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "アポEイソ蛋白のLDLーレセプタ-への結合能について" 動脈硬化. 18. 263-268 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "動脈硬化症におけるアポリポ蛋白異常" 動脈硬化研究の進歩. 11. 25-33 (1990)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "アポE isoform" 現代医療. 23. 171-174 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "アポEの異常と動脈硬化" 医学のあゆみ. 157. 832-836 (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] Li-Ming Dong: "Site-directed mutagenesis of an apoE mutant,apoE5(Glu_3→Lys):the binding activity of the expressed apoE5 to LDL receptor" Biochem.Biophys.Res.Commun.(1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "最新内科学大系36「動脈硬化と脈管疾患」「高脂血症」を分担" 中山書店, 394(108-115) (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] 山村 卓: "高脂血症「アポ蛋白とその役割り」を分担" 南江堂, 264(170-176) (1991)

    • Related Report
      1991 Annual Research Report
  • [Publications] LiーMing Dong: "Enhanced binding activity of an apolipoprotein E mutant,apo E5,to LDL receptors on human fibroblasts" Biochem.Biophys.Res.Commun.162. 409-414 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] Taku Yamamura: "Hyperlipoproteinemia as a risk factor for ischemic heart disease" Jpn.Circ.J.54. 448-456 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 山村 卓: "アポEイソ蛋白のLDLーレセプタ-への結合能について" 動脈硬化. 18. 263-268 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] Akira Yamamoto: "Risk factors for atherosclerotic vascular diseases with special reference to the relationship between apolipoprotein E mutants and hyperlipidemia" Ann.N.Y.Acad.Sci.598. 58-65 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 山村 卓: "動脈硬化症におけるアポリポ蛋白異常" 循環器病研究の進歩. 11. 25-33 (1990)

    • Related Report
      1990 Annual Research Report
  • [Publications] 山村 卓: "アポリポ蛋白異常と動脈硬化" 内科MOOK. 42. 70-81 (1990)

    • Related Report
      1990 Annual Research Report

URL: 

Published: 1990-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi